{
    "id": "601efda31cb411341a000069",
    "question": "Does bleomycin cause lung toxicity?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"Bleomycin is a chemotherapeutic agent used to treat various types of cancer, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, and testicular cancer. It is known to cause pulmonary toxicity as a significant side effect. The mechanism of this toxicity is thought to be related to the generation of reactive oxygen species (ROS) within the lung tissue, which can lead to damage to the alveolar epithelial cells and the endothelial cells of the pulmonary capillaries. This damage can result in inflammation, fibrosis, and eventually, pulmonary fibrosis. The risk of pulmonary toxicity is dose-dependent, and the incidence increases with higher cumulative doses. Therefore, it is essential to carefully monitor patients receiving bleomycin therapy for signs of pulmonary toxicity, such as dyspnea, cough, and chest pain. The American Joint Committee on Immunization Practices (JCI) and the National Comprehensive Cancer Network (NCCN) have established guidelines for the use of bleomycin, including recommendations for dose escalation and monitoring to minimize the risk of pulmonary toxicity.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 22.44644546508789
}